Skip to main content
Fig. 4 | BioMedical Engineering OnLine

Fig. 4

From: Hypoxia-inducible transcription factor-1α inhibition by topotecan protects against lipopolysaccharide-induced inflammation and apoptosis of cardiomyocytes

Fig. 4

Topotecan intervention abrogated the impact of HIF-1α-upregulation on the inflammation in LPS-induced H9c2 cells. A Cell viability was measured using a CCK-8 assay after topotecan treatment. B The expression of HIF-1α was tested by means of western blot analysis after topotecan intervention. *P < 0.05, **P < 0.01, ***P < 0.001 vs. control. CE ELISA kits were used to determine the levels of TNF-α, IL-6 and IL-8. ***P < 0.001 vs. control; ###P < 0.001 vs. LPS; P < 0.001 vs. LPS + pcDNA-HIF-1α

Back to article page